Abnormal dinitrochlorobenzene skin sensitization: A prognostic sign of survival in head and neck squamous cell carcinoma

Robert H. Maisel, Joseph H. Ogura

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Dinitrochlorobenzene (2-4 DNCB) forms a hapten with skin protein when topically applied. The delayed hypersensitivity reaction which secondary application produces is useful to measure cell-mediated immunity as a gross measure of cancer immunity. Lymphocytopenia and anergy to attempted delayed hypersensitivity elicitation may both reflect poor host response to neoplasia. A prospective study on 55 patients with localized or regional squamous cell carcinoma of the larynx, pharynx and mouth was done. These patients were sensitized and stimulated with DNCB and lymphocyte counts measured. Eighty-eight percent of positive DNCB reactors were alive and tumor free at one year while 53 percent of non-responders survived free of disease. All 19 DNCB responders with normal or increased lymphocyte counts survived without recurrence. The potential usefulness of prognostic evaluation of host response is described.

Original languageEnglish (US)
Pages (from-to)2012-2019
Number of pages8
JournalLaryngoscope
Volume83
Issue number12
DOIs
StatePublished - Jan 1 1973

Fingerprint

Dinitrochlorobenzene
Skin
Survival
Delayed Hypersensitivity
Lymphocyte Count
Neoplasms
Lymphopenia
Haptens
Larynx
Pharynx
Cellular Immunity
Mouth
Squamous Cell Carcinoma
Immunity
Carcinoma, squamous cell of head and neck
Prospective Studies
Recurrence
Proteins

Cite this

Abnormal dinitrochlorobenzene skin sensitization : A prognostic sign of survival in head and neck squamous cell carcinoma. / Maisel, Robert H.; Ogura, Joseph H.

In: Laryngoscope, Vol. 83, No. 12, 01.01.1973, p. 2012-2019.

Research output: Contribution to journalArticle

@article{64d0c0e50b8044538b54b8b2355c7261,
title = "Abnormal dinitrochlorobenzene skin sensitization: A prognostic sign of survival in head and neck squamous cell carcinoma",
abstract = "Dinitrochlorobenzene (2-4 DNCB) forms a hapten with skin protein when topically applied. The delayed hypersensitivity reaction which secondary application produces is useful to measure cell-mediated immunity as a gross measure of cancer immunity. Lymphocytopenia and anergy to attempted delayed hypersensitivity elicitation may both reflect poor host response to neoplasia. A prospective study on 55 patients with localized or regional squamous cell carcinoma of the larynx, pharynx and mouth was done. These patients were sensitized and stimulated with DNCB and lymphocyte counts measured. Eighty-eight percent of positive DNCB reactors were alive and tumor free at one year while 53 percent of non-responders survived free of disease. All 19 DNCB responders with normal or increased lymphocyte counts survived without recurrence. The potential usefulness of prognostic evaluation of host response is described.",
author = "Maisel, {Robert H.} and Ogura, {Joseph H.}",
year = "1973",
month = "1",
day = "1",
doi = "10.1288/00005537-197312000-00012",
language = "English (US)",
volume = "83",
pages = "2012--2019",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Abnormal dinitrochlorobenzene skin sensitization

T2 - A prognostic sign of survival in head and neck squamous cell carcinoma

AU - Maisel, Robert H.

AU - Ogura, Joseph H.

PY - 1973/1/1

Y1 - 1973/1/1

N2 - Dinitrochlorobenzene (2-4 DNCB) forms a hapten with skin protein when topically applied. The delayed hypersensitivity reaction which secondary application produces is useful to measure cell-mediated immunity as a gross measure of cancer immunity. Lymphocytopenia and anergy to attempted delayed hypersensitivity elicitation may both reflect poor host response to neoplasia. A prospective study on 55 patients with localized or regional squamous cell carcinoma of the larynx, pharynx and mouth was done. These patients were sensitized and stimulated with DNCB and lymphocyte counts measured. Eighty-eight percent of positive DNCB reactors were alive and tumor free at one year while 53 percent of non-responders survived free of disease. All 19 DNCB responders with normal or increased lymphocyte counts survived without recurrence. The potential usefulness of prognostic evaluation of host response is described.

AB - Dinitrochlorobenzene (2-4 DNCB) forms a hapten with skin protein when topically applied. The delayed hypersensitivity reaction which secondary application produces is useful to measure cell-mediated immunity as a gross measure of cancer immunity. Lymphocytopenia and anergy to attempted delayed hypersensitivity elicitation may both reflect poor host response to neoplasia. A prospective study on 55 patients with localized or regional squamous cell carcinoma of the larynx, pharynx and mouth was done. These patients were sensitized and stimulated with DNCB and lymphocyte counts measured. Eighty-eight percent of positive DNCB reactors were alive and tumor free at one year while 53 percent of non-responders survived free of disease. All 19 DNCB responders with normal or increased lymphocyte counts survived without recurrence. The potential usefulness of prognostic evaluation of host response is described.

UR - http://www.scopus.com/inward/record.url?scp=0015825403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015825403&partnerID=8YFLogxK

U2 - 10.1288/00005537-197312000-00012

DO - 10.1288/00005537-197312000-00012

M3 - Article

VL - 83

SP - 2012

EP - 2019

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -